NCT05323890 2023-03-14
Tislelizumab Combined With Neoadjuvant Radiotherapy and Chemotherapy for Resectable Esophageal Squamous Cell Carcinoma.
Shandong Cancer Hospital and Institute
Phase 2 Unknown
Clinical Trials
3 trialsNCT04437212 2020-06-26
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer
RenJi Hospital
Phase 2 Unknown
NCT03732508 2018-11-06
SHR-1316 in Combination With Chemotherapy in Patients With Esophageal Squamous Cell Cancer
Jiangsu HengRui Medicine Co., Ltd.
Phase 2 Unknown